Mood disorders in eating disorder patients: Prevalence and chronology of ONSET. Godart, N.; Radon, L.; Curt, F.; Duclos, J.; Perdereau, F.; Lang, F.; Venisse, J. L.; Halfon, O.; Bizouard, P.; Loas, G.; Corcos, M.; Jeammet, Ph; Flament, M. F.. Journal of Affective Disorders. 2015; 115-122: p.115-122. doi:10.1016/j.jad.2015.06.039Article
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium. Rup, B.; Pallardy, M.; Sikkema, D.; Albert, T.; Allez, M.; Broet, P.; Carini, C.; Creeke, P.; Davidson, J.; De Vries, N.; Finco, D.; Fogdell-Hahn, A.; Havrdova, E.; Hincelin-Mery, A.; C Holland, M.; H Jensen, P. E.; Jury, E. C.; Kirby, H.; Kramer, D.; Lacroix-Desmazes, S.; Legrand, J.; Maggi, E.; Maillère, B.; Mariette, X.; Mauri, C.; Mikol, V.; Mulleman, D.; Oldenburg, J.; Paintaud, G.; R Pedersen, C.; Ruperto, N.; Seitz, R.; Spindeldreher, S.; Deisenhammer, F.; ABIRISK Consortium. Clinical and Experimental Immunology. 2015; 181: p.385-400. doi:10.1111/cei.12652Article
[Comparison of two national quality of life surveys for patients with end stage renal disease between 2005-2007 and 2011: indicators slightly decreased]. Beauger, Davy; Gentile, Stéphanie; Jacquelinet, Christian; Dussol, Bertrand; Briançon, Serge. Néphrologie & Thérapeutique. 2015; 88-96: p.88-96. doi:10.1016/j.nephro.2014.10.003Article
Connective tissue problems and attention deficit and hyperactivity. Baeza-Velasco, Carolina; Soussana, Myriam; Baghdadli, Amaria. Attention Deficit and Hyperactivity Disorders. 2015; 177-178: p.177-178. doi:10.1007/s12402-014-0161-yArticle
Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD. Trivin, Claire; Metzger, Marie; Haymann, Jean-Philippe; Boffa, Jean-Jacques; Flamant, Martin; Vrtovsnik, François; Houillier, Pascal; Stengel, Benedicte; Thervet, Eric; NephroTest Study Group. Clinical journal of the American Society of Nephrology: CJASN. 2015; 957-964: p.957-964. doi:10.2215/CJN.08540814Article
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials. Doussau, A.; Thiebaut, R.; Geoerger, B.; Schoffski, P.; Floquet, A.; Le Deley, M. C.; Mathoulin-Pelissier, S.; Rizzo, E.; Fumoleau, P.; Le Tourneau, C.; Paoletti, X.. Ann Oncol. 2015; 422-8: p.422-8. doi:10.1093/annonc/mdu523 10.1093/annonc/mdu523. Epub 2014 Nov 17.Article
Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis. Deltombe, Olivier; Van Biesen, Wim; Glorieux, Griet; Massy, Ziad; Dhondt, Annemieke; Eloot, Sunny. Toxins. 2015; 7: p.3933-3946. doi:10.3390/toxins7103933Article
Unusual endomyocardial fibrosis with apical calcification. Gzara, H.; Berthelot, E.; Soyer, P.; Sirol, M.. Diagnostic and Interventional Imaging. 2015; : . doi:10.1016/j.diii.2015.04.009Article
Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: A study based on patient specific artery segments dose calculation. Moignier, A.; Broggio, D.; Derreumaux, S.; Beaudre, A.; Girinsky, T.; Paul, J. F.; Drubay, D.; Lefkopoulos, D.; Franck, D.; Aubert, B.; Deutsch, E.; Bourhis, J.. Radiother Oncol. 2015; 467-72: p.467-72. doi:10.1016/j.radonc.2015.07.043 10.1016/j.radonc.2015.07.043. Epub 2015 Aug 12.Article
Contribution of the low-frequency, loss-of-function p.R270H mutation in FFAR4 (GPR120) to increased fasting plasma glucose levels. Bonnefond, Amélie; Lamri, Amel; Leloire, Audrey; Vaillant, Emmanuel; Roussel, Ronan; Lévy-Marchal, Claire; Weill, Jacques; Galan, Pilar; Hercberg, Serge; Ragot, Stéphanie; Hadjadj, Samy; Charpentier, Guillaume; Balkau, Beverley; Marre, Michel; Fumeron, Frédéric; Froguel, Philippe. Journal of Medical Genetics. 2015; 52: p.595-598. doi:10.1136/jmedgenet-2015-103065Article